8-K ·Filed Apr 17, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
This is a routine corporate governance adjustment with no operational or financial implications. Traders should not expect any stock price movement from this filing.
Final — all horizons settled through T+60d
DARE ▼ -27.87% at T+60d
NEUTRAL call -27.87% · α vs SPY -34.65% · entry $2.87 → $2.07
T+1d
-17.77%
call -17.77% · α -17.12%
$2.36
settled 6mo ago
T+5d
-21.95%
call -21.95% · α -22.86%
$2.24
settled 6mo ago
T+20d
-26.48%
call -26.48% · α -30.68%
$2.11
settled 5mo ago
T+60d
-27.87%
call -27.87% · α -34.65%
$2.07
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Gregory W. Matz resigned as a Class II director and was immediately reappointed as a Class III director of Dare Bioscience for board class rebalancing ahead of the 2026 annual meeting. The move was administrative, with no change in his board service, committee roles, or responsibilities.
Key Facts
- Gregory W. Matz resigned as a Class II director and was reappointed as a Class III director effective April 16, 2026.
- The change was made solely to rebalance the classified board structure ahead of the 2026 annual meeting.
- Mr. Matz's board service is deemed uninterrupted, and there were no changes to his committee assignments.
- He will stand for re-election along with Sabrina Martucci Johnson at the 2026 annual meeting.
Financial Impact
No financial impact
governanceboard structure
Risk Factors
- None identified — this is a procedural board reclassification, not a leadership change.
- Low risk of misinterpretation as a substantive director departure if not read carefully.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001401914-26-000010 |
| Document: 0001401914-26-000010-index-headers.html | 0001401914-26-000010 |
| Document: 0001401914-26-000010-index.html | 0001401914-26-000010 |
| Document: 0001401914-26-000010.txt | 0001401914-26-000010 |
23 reports for DARE
71% Hit rate @ T+1 Went positive at some point 6 of 7 best @ T+60▲ +27.03%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
Showing 10 of 23
US Market Status
Market Open — Closes in 5h 17m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers